Endocannabinoid

Palmitoylethanolamide (PEA) was first discovered in 1957 as a component in egg yolk.   Image © MarkgrafAve / Getty Images

PEA may improve outcomes for Covid-19: Study

By Nicola Gordon-Seymour

Palmitoylethanolamide (PEA) may reduce inflammation and optimise immune responses to infectious conditions such as Covid-19, according to researchers in the USA.

 © lovelyday12 / Getty Images

PEA supplements may reduce joint discomfort: Study

By Stephen Daniells

Two weeks of supplementation with palmitoylethanolamide, an endocannabinoid-like molecule with potent anti-inflammatory properties, may reduce joint discomfort and improving quality of life in adults, says a new study.

© Getty Images KatarzynaBialasiewicz

CBD for mood: Going green to ease the blues

By Danielle Masterson

During these unprecedented times, many are undergoing a great amount of stress, leading many to seek out natural products to manage stress and boost their mood.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers